ScholarIQanswers from OpenAlex

Home-based pulmonary rehabilitation in people with bronchiectasis: a randomised controlled trial

PaperCitations, authors & open-access status

Home-based pulmonary rehabilitation in people with bronchiectasis: a randomised controlled trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Home-based pulmonary rehabilitation in people with bronchiectasis: a randomised controlled trial have?

ScholarIQcitation count

Home-based pulmonary rehabilitation in people with bronchiectasis: a randomised controlled trial has 30 citations in the OpenAlex counts ScholarIQ stores.

When was Home-based pulmonary rehabilitation in people with bronchiectasis: a randomised controlled trial published?

ScholarIQyear

Home-based pulmonary rehabilitation in people with bronchiectasis: a randomised controlled trial has 2021 year in the ScholarIQ index.

What is the open-access status of Home-based pulmonary rehabilitation in people with bronchiectasis: a randomised controlled trial?

ScholarIQoa status

Home-based pulmonary rehabilitation in people with bronchiectasis: a randomised controlled trial has gold oa status in the ScholarIQ index.

What is the DOI of Home-based pulmonary rehabilitation in people with bronchiectasis: a randomised controlled trial?

ScholarIQdoi

The DOI for Home-based pulmonary rehabilitation in people with bronchiectasis: a randomised controlled trial is on the source record.

What is the PMID of Home-based pulmonary rehabilitation in people with bronchiectasis: a randomised controlled trial?

ScholarIQpmid

The PMID for Home-based pulmonary rehabilitation in people with bronchiectasis: a randomised controlled trial is on the source record.

What is the OpenAlex record for Home-based pulmonary rehabilitation in people with bronchiectasis: a randomised controlled trial?

ScholarIQopenalex

The OpenAlex for Home-based pulmonary rehabilitation in people with bronchiectasis: a randomised controlled trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial